INTRODUCTION
The insulin-like growth factor I receptor (IGF-IR) is a transmembrane tyrosine kinase, the primary structure of which is highly homologous to that of the insulin receptor 1) ; both receptors consist of two extracellular α subunits and two intracellular β subunits containing the tyrosine kinase domain. The activation of IGF-IR by its ligands, IGF-I and -II, is known to play an important role in cell growth, transformation, protection from apoptosis, and differentiation [2] [3] [4] [5] . Some investigators, including us, report that IGF-IR was able to induce radioresistance following ionizing irradiation 6, 7) ; however, the downstream signaling pathways contributing to the mechanism still remain unknown.
Multiple signaling pathways originating from IGF-IR have been studied, including phosphatidylinositol-3 kinase (PI3-K), mitogen-activated protein kinase (MAPK), and 14-3-3 proteins 8, 9) . Of these, the PI3-K pathway is regarded as the primary survival signal, especially from studies using myeloid cells characteristic of IL-3-dependent cell growth and survival 8, 9) . Two potential sites within the IGF-IR structure are reported to stimulate the PI3-K: NPXY  950 and   Y   1316 XXM motif. The former is a binding site for insulin receptor substrate-1 (IRS-1) activating the reg-ulatory subunit p85 of PI3-K 10) . The latter is a direct binding site for the regulatory subunit p85, which stimulates PI3-K 11) . PI3-K stimulates Akt, which in turn stimulates Bad 12) , and thus exerts a survival effect. Each tyrosine of Y950 and Y1316 is reported to play a pivotal role in binding with IRS-1 and p85, respectively, using the yeast two hybrid system 10, 11) . In the present study, we explored the IGF-IR-mediated clonogenic radioresistant mechanism, focusing on the PI3-K pathway. For this purpose, the human IGF-IR with or without mutations at Y950/Y1316 was expressed in R-cells deficient in the endogenous IGF-IR 13) , and their radiosensitivities were evaluated by a colony-forming assay. Two specific inhibitors for PI3-K were also used as a different approach.
MATERIALS AND METHODS

Plasmid construction
The wild type, Y950F, and Y1316F receptor mutants were derived from human IGF-IR cDNA 1) , as described previously 14, 15) . For constructing double mutation, the HindIII-BamHI fragment of pBluescript SK Y950F 14) was replaced by the corresponding fragment of pBluescript SK Y1316F 15) , and was designated pBluescript SK Y950F/Y1316F. The XhoI-NotI of the pBPV IGF-IR 14, 15) , an expression plasmid for a wild type (WT) receptor, was then replaced by the corresponding fragment of pBluescript SK Y950F/ Y1316F including the double mutation.
Cell lines and transfection
R-cells are 3T3-like cells derived from mouse embryo fibroblasts with a targeted disruption of the IGF-IR gene 13) . Expression plasmids carrying a wild type or Y950F/Y1316F mutant cDNA were stably transfected into R-cells with a puromycin-resistant plasmid by the calcium phosphate technique, and cells were selected with 3 µ g/ml of puromycin. Resultant clones were used after screening by Western blotting, as described below. The clones used in this study were WT#11, Y950F/Y1316F#8, and Y950F/Y1316F#9. Mixed populations of cells with a marker gene alone were also established and designated R-(puro).
Western blots
IGF-IR levels and phosphorylation of IRS-1 and Akt were determined by Western blotting, as described previously 16 ).
Phosphatidylinositol-3 kinase (PI3-K) assay
A PI3-K assay was performed according to a method by Kobayashi et al. 17) using the anti-phosphotyrosine antibody immunoprecipitates from IGF-Iuntreated or -treated cells.
Colony-forming assay and PI3-K inhibitor treatment
The radiosensitivity of each cell line was determined by a colony-forming assay, as described previously 16) . For a PI3-K inhibitor treatment, cells grown on plastic flasks were incubated with wortmannin (Sigma Aldrich, St. Louis, Mo) or LY294002 (Sigma Aldrich) 1 h before irradiation. Cells were transferred to an incubator after irradiation, and rendered to form colonies in the presence of inhibitors. The multiplicity was ~1.1 at the time of irradiation, and a theoretical correction did not significantly change surviving fractions.
γ -irradiation γ -irradiation was performed using a 60
Co γ -ray therapeutic machine, RCR-120 (Toshiba, Tokyo, Japan), at a dose rate of 1.4 Gy/min.
RESULTS AND DISCUSSION
The IGF-IR expression levels in cells expressing WT or mutant receptors are shown in Fig. 1A . It was confirmed that IGF-IR expression in R-(puro) cells with the marker gene alone was not recognized by an anti-IGF-IR β subunit antibody by means of Western blotting. WT#11 and Y950F/Y1316F #9 clones expressed similar levels of IGF-IR, while the Y950F/ Y1316F #8 clone expressed fewer receptor levels (Fig.  1A) . When serum-deprived cells were stimulated with IGF-I, both mutant clones showed not abrogated, but significantly reduced activation of IRS-1, PI3-K, and Akt compared with those of the WT clone [ Fig.  1B(a),(b),(c) ]. This demonstrates that the ability to stimulate the PI3-K pathway is inhibited in Y950F/ Y1316F mutants. Despite such conditions, both mutant clones were radioresistant, to a similar extent, compared with the WT clone (Fig. 1C) . This observation also represents that the low level of receptor expression in the Y950F/Y1316F#9 mutant is sufficient to produce a saturated level of radioresistance. One may, however, argue that a slight activation of the PI3-K pathway is enough to induce clonogenic radioresistance. We therefore took another approach to inhibit the PI3-K pathway using specific inhibitors, wortmannin and LY294002. Low concentrations of inhibitors (wortmannin: 1 µ M; LY294002: 10 µ M), which are thought to be specific for PI3-K 18, 19) , were used for the present purpose. It is reported that higher concentrations of both inhibitors also inhibit ataxia telangiectasia-mutated (ATM) and DNA-dependent protein kinase (DNA-PK), crucial factors for DNA double-strand break repair. Indeed, IGF-I (50 ng/ml)-induced activation of Akt was almost completely abrogated under the conditions 1 h after treatment with wortmannin or LY294002 [ Fig. 1D(a) ]. Neither of the two inhibitors influenced the radioresistance, as shown in Fig1. D(b) . The incubation of cells with wortmannin at a concentration of 10 µ M significantly changed the surviving fraction at 6Gy, ~0.02, which is presumably due to the inhibition of ATM and DNA-PK, as reported 18) . Similar kinetics using Chinese hamster V79 cells was also reported by Tomita et al. 20) IGF-IR has the ability to strongly inhibit apoptosis triggered by various stimuli 4) . Survival signaling pathways from IGF-IR have been extensively studied mainly in terms of apoptosis induced by serum-or growth factor-deprived conditions 8, 9) . Such studies indicate that the PI3-K/Akt pathway plays a key role in the antiapoptotic effect. We, however, previously reported that IGF-IR is able to induce clonogenic radioresistance without conferring an antiapoptotic effect 16) . Indeed, the cell lines used in this study including R-cells exhibited similar levels of apoptosis, 20%, as determined by fractions of cells with the sub-G1 phase 72 h after 10 Gy of irradiation. This observation supports our previous report and suggests that the apoptotic response and clonogenic survival following irradiation may be biologically distinct, at least in these cell lines. It is thus of great interest whether the PI3-K/Akt pathway contributes to clonogenic radioresistance in these cell lines. Our results demonstrate that PI3-K activation-deficient mutants or specific inhibitors do not influence IGF-IR-mediated clonogenic radioresistance. A plausible explanation would be that the PI3-K pathway is not virtually involved in clonogenic radioresistance. However, the results also raise the possibility that alternative redundant pathways may exist in the mechanism, which confer full radioresistance in the absence of PI3-K pathway activation. In fact, the ability to stimulate MAPK (ERK-1,-2) was normally retained in the Y950F/Y1316F mutant (data not shown). Since MAPK and 14-3-3 protein-related survival signals downstream of IGF-IR are known to exert a cell survival effect 8, 9) , further mutational analysis targeting those pathways is required to elucidate the IGF-IRmediated clonogenic radioresistant mechanism irrelevant to the antiapoptotic activity; thereby the relative contribution of each pathway may be determined.
